Literature DB >> 8536717

Soluble human interleukin-6 receptor. Expression in insect cells, purification and characterization.

O Weiergräber1, U Hemmann, A Küster, G Müller-Newen, J Schneider, S Rose-John, P Kurschat, J P Brakenhoff, M H Hart, S Stabel.   

Abstract

The extracellular domain of the human interleukin-6 (IL-6) receptor, comprising 339 amino acids following the signal peptide, has been expressed in baculovirus-infected insect cells (Sf158). When the soluble receptor secreted into the culture medium was purified by affinity chromatography, using IL-6 immobilized on Sepharose, 6 mg soluble receptor was isolated from 1 l conditioned medium of Sf158 suspension cultures. A molar absorption coefficient of 9.3 x 10(4) l.mol-1.cm-1 was calculated from the ultraviolet spectrum of the soluble IL-6 receptor. After SDS/PAGE and silver staining, an apparent molecular mass of 48 kDa was estimated for the purified protein. Deglycosylation with peptide N-glycosidase F resulted in an increase in electrophoretic mobility and a decrease in the apparent molecular mass from 48 kDa to about 41-44 kDa. As expected, the soluble human IL-6 receptor bound human 125I-labeled IL-6 with low affinity (Kd = 500 pM). Furthermore, the binding of soluble human IL-6 receptor to immobilized IL-6 was studied using real-time interaction analysis. The recombinant soluble receptor showed biological activity on HepG2 cells stably transfected with a cDNA coding for IL-6 (HepG2-IL-6 cells). Haptoglobin mRNA synthesis was induced by the soluble IL-6 receptor at concentrations as low as 10 ng/ml. Five monoclonal antibodies were generated. Two groups of antibodies were identified mapping to amino acids 1-67 and 68-143 of the soluble IL-6 receptor, respectively. The plasma clearance of soluble 125I-labeled IL-6 receptor in the absence and presence of IL-6 was studied in rats as a model system. The kinetics was biphasic. Soluble IL-6 receptor/IL-6 complexes were cleared more rapidly than the soluble receptor alone. Intravenously injected soluble 125I-labeled IL-6 receptor, as well as complexes with IL-6, rapidly accumulated in liver and to a lesser extent in skeletal muscle, skin and kidneys. Subsequently, the radioactivity appeared in the gut content.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8536717     DOI: 10.1111/j.1432-1033.1995.661_b.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

1.  A single amino acid substitution (Trp(666)-->Ala) in the interbox1/2 region of the interleukin-6 signal transducer gp130 abrogates binding of JAK1, and dominantly impairs signal transduction.

Authors:  C Haan; H M Hermanns; P C Heinrich; I Behrmann
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

2.  Cytoplasmic STAT proteins associate prior to activation.

Authors:  S Haan; M Kortylewski; I Behrmann; W Müller-Esterl; P C Heinrich; F Schaper
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

Review 3.  A primer on cytokines: sources, receptors, effects, and inducers.

Authors:  J H Curfs; J F Meis; J A Hoogkamp-Korstanje
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

4.  Dynamics of the gp130 cytokine complex: a model for assembly on the cellular membrane.

Authors:  Andreas Schroers; Oliver Hecht; Karl-Josef Kallen; Michael Pachta; Stefan Rose-John; Joachim Grötzinger
Journal:  Protein Sci       Date:  2005-03       Impact factor: 6.725

5.  Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.

Authors:  H Dahmen; U Horsten; A Küster; Y Jacques; S Minvielle; I M Kerr; G Ciliberto; G Paonessa; P C Heinrich; G Müller-Newen
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

6.  Membrane lipid metabolism and phospholipase activity in insect Spodoptera frugiperda 9 ovarian cells.

Authors:  L H Yeh; R K Bajpai; G Y Sun
Journal:  Lipids       Date:  1997-05       Impact factor: 1.880

7.  A panel of four cytokines predicts the prognosis of patients with malignant gliomas.

Authors:  Yi Lin; Guozhen Zhang; Jing Zhang; Guangzu Gao; Min Li; Yong Chen; Jiangfei Wang; Guilin Li; Sonya-Wei Song; Xiaoguang Qiu; Yunjie Wang; Tao Jiang
Journal:  J Neurooncol       Date:  2013-06-08       Impact factor: 4.130

8.  Connective tissue growth factor reacts as an IL-6/STAT3-regulated hepatic negative acute phase protein.

Authors:  Olav A Gressner; Ieva Peredniene; Axel M Gressner
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

9.  The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.

Authors:  Patrick Fischer; Ute Lehmann; Radoslaw M Sobota; Jochen Schmitz; Claudia Niemand; Sonja Linnemann; Serge Haan; Iris Behrmann; Akihiko Yoshimura; James A Johnston; Gerhard Müller-Newen; Peter C Heinrich; Fred Schaper
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

10.  Dominant-negative activity of the STAT3-Y705F mutant depends on the N-terminal domain.

Authors:  Anne Mohr; Dirk Fahrenkamp; Natalie Rinis; Gerhard Müller-Newen
Journal:  Cell Commun Signal       Date:  2013-11-05       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.